Abbott India Share Price

<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Abbott India announced Q2FY27 results</strong></span></h3> <p><strong>Financial Highlights:</strong></p> <ul data-complete="true" data-hveid="CAAIChAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="RjAONe_1t"> <li data-complete="true" data-hveid="CAAIChAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_1w"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_1y">Revenue from operations:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue from operations was recorded at Rs 1,951.01 crore, displaying a growth of 7.57% QoQ from Rs 1,813.68 crore in Q1FY27 and a growth of 11.03% YoY from Rs 1,757.15 crore in Q2FY26. For H1FY27, revenue from operations reached Rs 3,764.69 crore, demonstrating a YoY growth of 7.7% against Rs 3,495.50 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAF" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_26"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_28">Total income:<!--TgQPHd|||[]--></strong> For Q2FY27, total income stood at Rs 2,019.07 crore, increasing by 6.88% QoQ from Rs 1,889.05 crore in Q1FY27 and up 10.51% YoY from Rs 1,827.10 crore in Q2FY26. For H1FY27, total income amounted to Rs 3,908.12 crore, up 7.42% YoY compared to Rs 3,638.29 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAI" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_2g"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_2i">Profit Before Tax (PBT):<!--TgQPHd|||[]--></strong> For Q2FY27, PBT reached Rs 610.47 crore, scaling up by 6.69% QoQ from Rs 572.21 crore in Q1FY27 and increasing by 11.82% YoY from Rs 545.93 crore in Q2FY26. For H1FY27, PBT expanded to Rs 1,182.68 crore, growing by 13.82% YoY against Rs 1,039.05 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAL" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_2q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_2s">Profit After Tax (PAT):<!--TgQPHd|||[]--></strong> For Q2FY27, PAT or net profit was reported at Rs 453.45 crore, higher by 5.82% QoQ than Rs 428.52 crore in Q1FY27 and higher by 9.19% YoY than Rs 415.27 crore in Q2FY26. For H1FY27, PAT stood at Rs 881.97 crore, showing a YoY growth of 12.91% compared to Rs 781.13 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAO" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_30"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_32">Earnings per share (EPS):<!--TgQPHd|||[]--></strong> For Q2FY27, basic and diluted EPS was recorded at Rs 213.39, expanding by 5.82% QoQ from Rs 201.66 in Q1FY27 and growing by 9.2% YoY over Rs 195.42 in Q2FY26. For H1FY27, basic and diluted EPS stood at Rs 415.04, reflecting a YoY growth of 12.91% compared to Rs 367.59 in H1FY26.<!--TgQPHd|||[]--></li> </ul> <p> </p> <p><a class="lb" href="/get-document/post/pdf/5934828/" target="_blank">Result PDF</a></p>

• Trendlyne
• 4 days 8 hours ago

Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.

• BSE India
• 5 days 1 hour ago

Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.

• BSE India
• 5 days 2 hours ago